Introduction
Becker muscular dystrophy (BMD) is an X-linked neuromuscular disorder caused by mutations in the dystrophin gene and characterized by progressive muscle weakness. Myocardial involvement is less frequent among patients with BMD than in those with Duchenne muscular dystrophy, and most commonly takes the form of a dilated cardiomyopathy. There have also been isolated reports of hypertrophic cardiomyopathy (HCM) in association with BMD, but it is unclear whether these patients had an
Learning point
• This case highlights the importance of considering additional aetiologies of cardiac disease in the presence of infrequent phenotypic expressions in neuromuscular disorders. Figure 1 ). The echocardiogram showed asymmetric septal hypertrophy affecting primarily the anteroseptal wall and extending more distally towards the apex. Maximal left ventricular wall thickness was 18 mm at the mid-septum. The left ventricular cavity was relatively small and globally hyperdynamic. Left ventricular diastolic performance was normal and left atrial dimensions were also normal. There was no systolic anterior motion of the mitral valve or left ventricular outflow tract obstruction at rest (Figure 2) . A cardiac magnetic resonance imaging was performed, confirming an asymmetric septal hypertrophy affecting primarily the basal and mid septum with a maximal left ventricular wall thickness of 18 mm and no left ventricular outflow tract obstruction ( Figure 3A ). There was patchy late gadolinium enhancement of the hypertrophied myocardium ( Figure 3B ). c.2701G>C; p.Ala901Pro). Family screening for this mutation has been recommended but has not been undertaken to date. The only family member with a history of cardiac disease was the maternal grandfather, who was reported to have undergone a heart transplant due to cardiac sarcoidosis and had died in his forties as a result of subsequent rejection. There was no history of premature cardiac disease or sudden cardiac death in any other family members.
The patient remains asymptomatic from a cardiac point of view without treatment, with no progression of his wall thickness on his follow-up echocardiograms at 1 year. As the concomitant diagnosis of BMD and sarcomeric HCM has not been previously reported in childhood, it is unclear how and whether this combination will affect his prognosis, but he will require regular cardiac follow-up. 
Conclusion
We present a patient with BMD and sarcomeric HCM, representing the first report of a paediatric patient affected with BMD and with sarcomeric HCM. His neuromuscular presentation is in keeping with BMD with no features suggestive of MHY7 gene-related congenital myopathy. The combination of neuromuscular symptoms and left ventricular hypertrophy should prompt a search for alternative differential diagnoses, including inborn errors of metabolism such as glycogen storage diseases or, in an adult, Fabry disease. This case, however, highlights the importance of considering additional aetiologies of cardiac disease in the presence of infrequent phenotypic expressions in neuromuscular disorders. Although isolated cases of HCM have been previously described in patients with BMD, the present case suggests that this is likely to be a concomitant disorder rather than a cardiac manifestation of BMD. 
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